{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:52:14Z","timestamp":1792763534628,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010121066"],"award-info":[{"award-number":["6010121066"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>POU5F1 plays an important role in maintaining the cancer stem cell (CSC) -like properties of gastric cancer (GC) cells. The impact of POU5F1 on the proliferation and metastasis of GC was examined, along with the potential of ATRA as a specific therapeutic agent for GC. The dysregulation of POU5F1 expression in GC tissues was analyzed using public databases and bioinformatics techniques, and the disparity in POU5F1 expression between normal gastric tissues and GC tissues was further assessed through western blot, RT-qPCR, and immunohistochemistry. The present study aimed to investigate the impact of POU5F1 on the proliferation, migration, and invasion of GC cells through both in vivo and in vitro experiments. Additionally, the effects of ATRA on the proliferation, migration, and invasion of GC cells were examined using in vivo and in vitro approaches. Our findings revealed a significant upregulation of POU5F1 in GC tissues, which was found to be associated with a poorer prognosis in patients with GC. Moreover, POU5F1 was observed to enhance the proliferation, migration, and invasion of GC cells in vitro, as well as promote subcutaneous tumor growth and lung metastasis of GC cells in vivo. The overexpression of POU5F1 mechanistically triggers the process of Epithelial-mesenchymal transition (EMT) by down-regulating E-Cadherin and up-regulating N-Cadherin and VIM. POU5F1 hinders the ubiquitination of TRAF6 through negative regulation of TRIM59, thereby facilitating the activation of the NF-\u03baB pathway. Furthermore, the administration of ATRA effectively impedes the proliferation, migration, and invasion of GC cells by suppressing the expression of POU5F1. The upregulation of POU5F1 elicits EMT, fosters the initiation of the NF-\u03baB signaling pathway in GC cells, and stimulates the proliferation, invasion, and metastasis of GC cells. All-trans retinoic acid (ATRA) can impede these POU5F1-induced effects, thereby potentially serving as an adjunctive therapeutic approach for GC.<\/jats:p>","DOI":"10.1038\/s41419-023-06332-8","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:02:56Z","timestamp":1701961376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6"],"prefix":"10.1038","volume":"14","author":[{"given":"Wenshuo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7111-3780","authenticated-orcid":false,"given":"Wenbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"6332_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20:338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"key":"6332_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA: Cancer J Clin"},{"key":"6332_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"6332_CR4","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA: Cancer J Clin"},{"key":"6332_CR5","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"S-H Chiou","year":"2010","unstructured":"Chiou S-H, Wang M-L, Chou Y-T, Chen C-J, Hong C-F, Hsieh W-J, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010;70:10433\u201344.","journal-title":"Cancer Res"},{"key":"6332_CR6","doi-asserted-by":"publisher","first-page":"e10709","DOI":"10.1371\/journal.pone.0010709","volume":"5","author":"M Jung","year":"2010","unstructured":"Jung M, Peterson H, Chavez L, Kahlem P, Lehrach H, Vilo J, et al. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS ONE. 2010;5:e10709.","journal-title":"PLoS ONE"},{"key":"6332_CR7","doi-asserted-by":"publisher","first-page":"165432","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin IS, Wei S-J, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165432.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6332_CR8","doi-asserted-by":"publisher","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"Y-C Chen","year":"2008","unstructured":"Chen Y-C, Hsu H-S, Chen Y-W, Tsai T-H, How C-K, Wang C-Y, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE. 2008;3:e2637.","journal-title":"PLoS ONE"},{"key":"6332_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-016-0359-2","volume":"35","author":"S Kaufhold","year":"2016","unstructured":"Kaufhold S, Garb\u00e1n H, Bonavida B. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res. 2016;35:84.","journal-title":"J Exp Clin Cancer Res"},{"key":"6332_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s12015-020-10098-3","volume":"17","author":"M Mehravar","year":"2021","unstructured":"Mehravar M, Ghaemimanesh F, Poursani EM. An overview on the complexity of OCT4: at the level of DNA, RNA and protein. Stem Cell Rev Rep. 2021;17:1121\u201336.","journal-title":"Stem Cell Rev Rep"},{"key":"6332_CR11","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1074\/jbc.C400587200","volume":"280","author":"D Pain","year":"2005","unstructured":"Pain D, Chirn G-W, Strassel C, Kemp DM. Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem. 2005;280:6265\u20138.","journal-title":"J Biol Chem"},{"key":"6332_CR12","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3892\/or.2015.3862","volume":"33","author":"D Li","year":"2015","unstructured":"Li D, Yang Z-K, Bu J-Y, Xu C-Y, Sun H, Tang J-B, et al. OCT4B modulates OCT4A expression as ceRNA in tumor cells. Oncol Rep. 2015;33:2622\u201330.","journal-title":"Oncol Rep"},{"key":"6332_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/sj.embor.7400279","volume":"5","author":"J Kehler","year":"2004","unstructured":"Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M, et al. Oct4 is required for primordial germ cell survival. EMBO Rep. 2004;5:1078\u201383.","journal-title":"EMBO Rep"},{"key":"6332_CR14","first-page":"2244","volume":"63","author":"LHJ Looijenga","year":"2003","unstructured":"Looijenga LHJ, Stoop H, de Leeuw HPJC, de Gouveia Brazao CA, Gillis AJM, van Roozendaal KEP, et al. POU5F1 (OCT3\/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244\u201350.","journal-title":"Cancer Res"},{"key":"6332_CR15","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1038\/onc.2011.656","volume":"31","author":"SM Kumar","year":"2012","unstructured":"Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 2012;31:4898\u2013911.","journal-title":"Oncogene."},{"key":"6332_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jso.21270","volume":"99","author":"Z Chen","year":"2009","unstructured":"Chen Z, Xu W-R, Qian H, Zhu W, Bu X-F, Wang S, et al. Oct4, a novel marker for human gastric cancer. J Surg Oncol. 2009;99:414\u20139.","journal-title":"J Surg Oncol"},{"key":"6332_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jcb.23374","volume":"113","author":"K Kobayashi","year":"2012","unstructured":"Kobayashi K, Takahashi H, Inoue A, Harada H, Toshimori S, Kobayashi Y, et al. Oct-3\/4 promotes migration and invasion of glioblastoma cells. J Cell Biochem. 2012;113:508\u201317.","journal-title":"J Cell Biochem"},{"key":"6332_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0022-5347(01)68313-7","volume":"174","author":"JP Richie","year":"2005","unstructured":"Richie JP. OCT4 staining in testicular tumors. A sensitive and specific marker for seminoma and embryonal carcinoma. J Urol. 2005;174:569\u201370.","journal-title":"J Urol"},{"key":"6332_CR19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/modpathol.2013.110","volume":"26","author":"MT Idrees","year":"2013","unstructured":"Idrees MT, Williamson SR, Kieffer TW, Cheng L. The role of OCT4 immunohistochemistry in evaluation of retroperitoneal lymph node dissections: a pilot study. Mod Pathol. 2013;26:1613\u20139.","journal-title":"Mod Pathol"},{"key":"6332_CR20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ijc.22508","volume":"120","author":"Y Atlasi","year":"2007","unstructured":"Atlasi Y, Mowla SJ, Ziaee SAM, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 2007;120:1598\u2013602.","journal-title":"Int J Cancer"},{"key":"6332_CR21","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1158\/0008-5472.CAN-12-4403","volume":"73","author":"C Xu","year":"2013","unstructured":"Xu C, Xie D, Yu S-C, Yang X-J, He L-R, Yang J, et al. \u03b2-Catenin\/POU5F1\/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res. 2013;73:3181\u20139.","journal-title":"Cancer Res"},{"key":"6332_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2012.03.017","volume":"338","author":"CAM La Porta","year":"2013","unstructured":"La Porta CAM, Zapperi S. Human breast and melanoma cancer stem cells biomarkers. Cancer Lett. 2013;338:69\u201373.","journal-title":"Cancer Lett"},{"key":"6332_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1369\/0022155414532654","volume":"62","author":"L Shen","year":"2014","unstructured":"Shen L, Huang X, Xie X, Su J, Yuan J, Chen X. High expression of SOX2 and OCT4 indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma. J Histochem Cytochem. 2014;62:499\u2013509.","journal-title":"J Histochem Cytochem"},{"key":"6332_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni0901-835","volume":"2","author":"T Horng","year":"2001","unstructured":"Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol. 2001;2:835\u201341.","journal-title":"Nat Immunol"},{"key":"6332_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001;413:78\u201383.","journal-title":"Nature."},{"key":"6332_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0378-1119(02)00603-0","volume":"291","author":"R Chang","year":"2002","unstructured":"Chang R, Xu X, Li MD. Molecular cloning, mapping and characterization of a novel mouse RING finger gene, Mrf1. Gene. 2002;291:241\u20139.","journal-title":"Gene."},{"key":"6332_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"X-H Tang","year":"2011","unstructured":"Tang X-H, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol. 2011;6:345\u201364.","journal-title":"Annu Rev Pathol"},{"key":"6332_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-018-1017-7","volume":"38","author":"NA Lokman","year":"2019","unstructured":"Lokman NA, Ho R, Gunasegaran K, Bonner WM, Oehler MK, Ricciardelli C. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer. J Exp Clin Cancer Res. 2019;38:10.","journal-title":"J Exp Clin Cancer Res"},{"key":"6332_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2004.12.016","volume":"103","author":"G Zuccari","year":"2005","unstructured":"Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J Controlled Rel. 2005;103:369\u201380.","journal-title":"J Controlled Rel"},{"key":"6332_CR30","first-page":"1026","volume":"14","author":"E Pikarsky","year":"1994","unstructured":"Pikarsky E, Sharir H, Ben-Shushan E, Bergman Y. Retinoic acid represses Oct-3\/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol. 1994;14:1026\u201338.","journal-title":"Mol Cell Biol"},{"key":"6332_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/1078-0432.CCR-07-1047","volume":"14","author":"C-L Wu","year":"2008","unstructured":"Wu C-L, Shieh G-S, Chang C-C, Yo Y-T, Su C-H, Chang M-Y, et al. Tumor-selective replication of an oncolytic adenovirus carrying oct-3\/4 response elements in murine metastatic bladder cancer models. Clin Cancer Res. 2008;14:1228\u201338.","journal-title":"Clin Cancer Res"},{"key":"6332_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-051019-103216","volume":"72","author":"ND Pilonis","year":"2021","unstructured":"Pilonis ND, Tischkowitz M, Fitzgerald RC, di Pietro M. Hereditary diffuse gastric cancer: approaches to screening, surveillance, and treatment. Annu Rev Med. 2021;72:263\u201380.","journal-title":"Annu Rev Med"},{"key":"6332_CR33","first-page":"1479","volume":"125","author":"J-H Li","year":"2012","unstructured":"Li J-H, Zhang S-W, Liu J, Shao M-Z, Chen L. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J. 2012;125:1479\u201395.","journal-title":"Chin Med J"},{"key":"6332_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0092-8674(00)81769-9","volume":"95","author":"J Nichols","year":"1998","unstructured":"Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379\u201391.","journal-title":"Cell."},{"key":"6332_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/carcin\/bgh321","volume":"26","author":"M-H Tai","year":"2005","unstructured":"Tai M-H, Chang C-C, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005;26:495\u2013502.","journal-title":"Carcinogenesis."},{"key":"6332_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/jjco\/hyq066","volume":"40","author":"X Zhang","year":"2010","unstructured":"Zhang X, Han B, Huang J, Zheng B, Geng Q, Aziz F, et al. Prognostic significance of OCT4 expression in adenocarcinoma of the lung. Jpn J Clin Oncol. 2010;40:961\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"6332_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/15548627.2016.1260808","volume":"13","author":"T Sharif","year":"2017","unstructured":"Sharif T, Martell E, Dai C, Kennedy BE, Murphy P, Clements DR, et al. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 2017;13:264\u201384.","journal-title":"Autophagy."},{"key":"6332_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13072-021-00432-5","volume":"14","author":"C Baumann","year":"2021","unstructured":"Baumann C, Zhang X, Zhu L, Fan Y, De La Fuente R. Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells. Epigenetics Chromatin. 2021;14:58.","journal-title":"Epigenetics Chromatin"},{"key":"6332_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","volume":"588","author":"Y Lu","year":"2020","unstructured":"Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588:124\u20139.","journal-title":"Nature."},{"key":"6332_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/iub.580","volume":"64","author":"LM Napolitano","year":"2012","unstructured":"Napolitano LM, Meroni G. TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life. 2012;64:64\u201371.","journal-title":"IUBMB Life"},{"key":"6332_CR41","doi-asserted-by":"crossref","unstructured":"Xuan JW. Abstract 237: A novel proto-oncogene of TRIM59 characterized in mouse cancer models bridging Ras and pRb signal pathways. Cancer Res. 2010;70(8_Supplement):237.","DOI":"10.1158\/1538-7445.AM10-237"},{"key":"6332_CR42","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/j.gastro.2014.07.021","volume":"147","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, et al. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Gastroenterology. 2014;147:1043\u201354.","journal-title":"Gastroenterology"},{"key":"6332_CR43","first-page":"6","volume":"21","author":"R Liu","year":"2021","unstructured":"Liu R, Li H, Xu Y, Li X, Guo X, Shi J, et al. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncol Lett. 2021;21:6.","journal-title":"Oncol Lett"},{"key":"6332_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","volume":"110","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Hernandez LD, Gal\u00e1n JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 2002;110:191\u2013202.","journal-title":"Cell."},{"key":"6332_CR45","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature736","volume":"416","author":"N Suzuki","year":"2002","unstructured":"Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 2002;416:750\u20136.","journal-title":"Nature."},{"key":"6332_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","volume":"16","author":"K Takeda","year":"2004","unstructured":"Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3\u20139.","journal-title":"Semin Immunol"},{"key":"6332_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/jop.12709","volume":"47","author":"Y Liang","year":"2018","unstructured":"Liang Y, Jiao J, Liang L, Zhang J, Lu Y, Xie H, et al. Tumor necrosis factor receptor-associated factor 6 mediated the promotion of salivary adenoid cystic carcinoma progression through Smad-p38-JNK signaling pathway induced by TGF-\u03b2. J Oral Pathol Med. 2018;47:583\u20139.","journal-title":"J Oral Pathol Med"},{"key":"6332_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12302","volume":"266","author":"MC Walsh","year":"2015","unstructured":"Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 2015;266:72\u201392.","journal-title":"Immunol Rev"},{"key":"6332_CR49","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1172\/JCI58818","volume":"121","author":"DT Starczynowski","year":"2011","unstructured":"Starczynowski DT, Lockwood WW, Del\u00e9houz\u00e9e S, Chari R, Wegrzyn J, Fuller M, et al. TRAF6 is an amplified oncogene bridging the RAS and NF-\u03baB pathways in human lung cancer. J Clin Investig. 2011;121:4095\u2013105.","journal-title":"J Clin Investig"},{"key":"6332_CR50","doi-asserted-by":"publisher","first-page":"e23931","DOI":"10.5812\/ircmj.23931","volume":"18","author":"T Zhang","year":"2016","unstructured":"Zhang T, Wang H, Han L. Expression and clinical significance of tumor necrosis factor receptor-associated factor 6 in patients with colon cancer. Iran Red Crescent Med J. 2016;18:e23931.","journal-title":"Iran Red Crescent Med J."},{"key":"6332_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/15592294.2014.1003746","volume":"10","author":"D Sarkar","year":"2015","unstructured":"Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME. Epigenetic regulation in human melanoma: past and future. Epigenetics 2015;10:103\u201321.","journal-title":"Epigenetics"},{"key":"6332_CR52","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1158\/0008-5472.CAN-13-0370","volume":"73","author":"H Sun","year":"2013","unstructured":"Sun H, Li X-B, Meng Y, Fan L, Li M, Fang J. TRAF6 upregulates expression of HIF-1\u03b1 and promotes tumor angiogenesis. Cancer Res. 2013;73:4950\u20139.","journal-title":"Cancer Res"},{"key":"6332_CR53","doi-asserted-by":"publisher","first-page":"113451","DOI":"10.1016\/j.ejmech.2021.113451","volume":"220","author":"C Liang","year":"2021","unstructured":"Liang C, Qiao G, Liu Y, Tian L, Hui N, Li J, et al. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. Eur J Med Chem. 2021;220:113451.","journal-title":"Eur J Med Chem"},{"key":"6332_CR54","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1517\/14656560903505115","volume":"11","author":"F Ferrara","year":"2010","unstructured":"Ferrara F. Acute promyelocytic leukemia: what are the treatment options? Expert Opin Pharmacother. 2010;11:587\u201396.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06332-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:03:28Z","timestamp":1701961408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6332"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06332-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the Qilu Hospital of Shandong University Research Ethics Committee. Approval number: KYLL-202209-047; KYLL-2023(ZM)-004.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"802"}}